Iovance Biotherapeutics
IOVA
IOVA
227 hedge funds and large institutions have $970M invested in Iovance Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 107 increasing their positions, 52 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4.86% less ownership
Funds ownership: 90.88% → 86.01% (-4.9%)
32% less capital invested
Capital invested by funds: $1.44B → $970M (-$466M)
Holders
227
Holding in Top 10
3
Calls
$33.7M
Puts
$16.2M
Top Buyers
| 1 | +$52.2M | |
| 2 | +$27.7M | |
| 3 | +$20.7M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$19.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$12.3M |
Top Sellers
| 1 | -$41.6M | |
| 2 | -$18.3M | |
| 3 | -$17.5M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$17.5M |
| 5 |
PA
Perceptive Advisors
New York
|
-$13.5M |